SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 10.30 |
Enterprise Value ($M) | 85.24 |
Book Value ($M) | 64.28 |
Book Value / Share | 48.25 |
Price / Book | 0.16 |
NCAV ($M) | -13.48 |
NCAV / Share | -10.12 |
Price / NCAV | -0.76 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.15 |
Return on Assets (ROA) | -2.96 |
Return on Equity (ROE) | -2.59 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 5.21 |
Current Ratio | 5.21 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 16.54 |
Assets | 94.31 |
Liabilities | 30.03 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -12.23 |
Net Income | -12.35 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D | Sealbond Ltd | 15.90 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
192,054 | 690,274 | 27.82 | |
236,590 | 785,356 | 30.13 | |
1,845,403 | 5,854,019 | 31.52 | |
4,443,037 | 12,607,442 | 35.24 | |
3,494,498 | 10,358,572 | 33.74 | |
(click for more detail) |
Similar Companies | |
---|---|
DRRX – DURECT Corporation | DRUG – Bright Minds Biosciences Inc. |
DTIL – Precision BioSciences, Inc. | DYAI – Dyadic International, Inc. |
EDSA – Edesa Biotech, Inc. |
Financial data and stock pages provided by
Fintel.io